Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lomudal in Young Athletes with EIB
NCT04408664Phase 3Terminated
- Sponsor
- UZ Leuven
- Start
- Apr 2021
- Primary completion
- Jun 2023
- Countries
- 1
01
Overview
A Phase 3 trial of sodium cromoglycate in Exercise-induced bronchoconstriction (EIB), sponsored by UZ Leuven. Started Apr 2021; status: terminated.
02
Drugs
sodium cromoglycate
03
Conditions
Exercise-induced bronchoconstriction (EIB)
Beyond the preview
Go deeper on NCT04408664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04408664.